An observational study in Paget Schroetter Syndrome, sponsored by Sheba Medical Center. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-06-06.
Sponsored by Sheba Medical Center · Observational
The purpose of the study is to compare outcome of patients with effort thrombosis who were treated operatively to those treated nonoperatively
1,506 studies on the registry are indexed under Thrombosis; 238 are open to participants now.
This study's planned enrollment of 20 is below the median of 213 across 586 observational studies indexed under Thrombosis.
Browse Thrombosis studies →Sheba Medical Center is the lead sponsor of 660 studies on the registry; 63 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients who were previously treated for upper extremity DVT ( anticoagulation- with or without 1st rib resection)
Inclusion Criteria:\
* patients treated for upper extremity DVT
Exclusion Criteria:
operative
Device: iu22 ultrasound system - phillips
non operative
Device: iu22 ultrasound system - phillips
iu22 ultrasound system - phillips
clinical differences
clinical differences between the 2 groups Patients will be evaluated by the " Villata" post thrombotic syndrome (PTS) scoring system. The sum of each parameter will be used to compare he groups Vilata PTS scoring system: ( 0- ABSENT , 3 SEVERE ) Symptoms/clinical signs None Mild Moderate Severe Symptoms Pain Cramps Heaviness Pruritus Clinical signs edema Skin induration Hyperpigmentation Redness Venous ectasia Pain on calf compression
Time frame: 10years
vein patency
patency of SCV based on duplex
Time frame: 10 years
No study locations are listed for this record.
This study is status unknown, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sheba Medical Center